1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
insider
insider
Articles 

Sofinnova Ventures Inc Buys Alexion Pharmaceuticals Inc, Merck Inc, Align Technology Inc, Sells Regeneron Pharmaceuticals Inc, Biomarin Pharmaceutical Inc, Mirati Therapeutics Inc

Investment company Sofinnova Ventures Inc (Current Portfolio) buys Alexion Pharmaceuticals Inc, Merck Inc, Align Technology Inc, Puma Biotechnology Inc, Heron Therapeutics Inc, sells Regeneron Pharmaceuticals Inc, Biomarin Pharmaceutical Inc, Mirati Therapeutics Inc, Macrogenics Inc, ChemoCentryx Inc during the 3-months ended 2020Q1, according to the most recent filings of the investment company, Sofinnova Ventures Inc. As of 2020Q1, Sofinnova Ventures Inc owns 55 stocks with a total value of $1 billion. These are the details of the buys and sells.

For the details of Sofinnova Ventures Inc's stock buys and sells, go to https://www.gurufocus.com/guru/sofinnova+ventures+inc/current-portfolio/portfolio

These are the top 5 holdings of Sofinnova Ventures Inc
  1. Karuna Therapeutics Inc (KRTX) - 1,885,602 shares, 13.51% of the total portfolio.
  2. Ascendis Pharma A/S (ASND) - 1,109,874 shares, 12.43% of the total portfolio.
  3. NextCure Inc (NXTC) - 2,671,856 shares, 9.85% of the total portfolio.
  4. Natera Inc (NTRA) - 3,100,560 shares, 9.21% of the total portfolio.
  5. Principia Biopharma Inc (PRNB) - 1,417,258 shares, 8.37% of the total portfolio.
New Purchase: Alexion Pharmaceuticals Inc (ALXN)

Sofinnova Ventures Inc initiated holding in Alexion Pharmaceuticals Inc. The purchase prices were between $75.56 and $113.92, with an estimated average price of $98.6. The stock is now traded at around $101.65. The impact to a portfolio due to this purchase was 2.75%. The holding were 307,300 shares as of .

New Purchase: Align Technology Inc (ALGN)

Sofinnova Ventures Inc initiated holding in Align Technology Inc. The purchase prices were between $137.72 and $298.07, with an estimated average price of $241.25. The stock is now traded at around $206.45. The impact to a portfolio due to this purchase was 0.8%. The holding were 46,500 shares as of .

New Purchase: Puma Biotechnology Inc (PBYI)

Sofinnova Ventures Inc initiated holding in Puma Biotechnology Inc. The purchase prices were between $6.28 and $14.57, with an estimated average price of $9.74. The stock is now traded at around $12.29. The impact to a portfolio due to this purchase was 0.54%. The holding were 638,026 shares as of .

New Purchase: Axsome Therapeutics Inc (AXSM)

Sofinnova Ventures Inc initiated holding in Axsome Therapeutics Inc. The purchase prices were between $41.2 and $103.36, with an estimated average price of $82.09. The stock is now traded at around $89.58. The impact to a portfolio due to this purchase was 0.43%. The holding were 73,163 shares as of .

New Purchase: AbbVie Inc (ABBV)

Sofinnova Ventures Inc initiated holding in AbbVie Inc. The purchase prices were between $64.5 and $97.79, with an estimated average price of $85.41. The stock is now traded at around $90.46. The impact to a portfolio due to this purchase was 0.38%. The holding were 50,000 shares as of .

New Purchase: Blueprint Medicines Corp (BPMC)

Sofinnova Ventures Inc initiated holding in Blueprint Medicines Corp. The purchase prices were between $48.11 and $82.22, with an estimated average price of $64.89. The stock is now traded at around $63.33. The impact to a portfolio due to this purchase was 0.37%. The holding were 63,100 shares as of .

Added: Merck & Co Inc (MRK)

Sofinnova Ventures Inc added to a holding in Merck & Co Inc by 92.60%. The purchase prices were between $66.4 and $92.04, with an estimated average price of $82.63. The stock is now traded at around $77.19. The impact to a portfolio due to this purchase was 1.71%. The holding were 463,795 shares as of .

Added: Heron Therapeutics Inc (HRTX)

Sofinnova Ventures Inc added to a holding in Heron Therapeutics Inc by 853.68%. The purchase prices were between $10.23 and $24.53, with an estimated average price of $18.95. The stock is now traded at around $14.67. The impact to a portfolio due to this purchase was 0.5%. The holding were 481,608 shares as of .

Added: United Therapeutics Corp (UTHR)

Sofinnova Ventures Inc added to a holding in United Therapeutics Corp by 23.81%. The purchase prices were between $79.39 and $115.35, with an estimated average price of $95.05. The stock is now traded at around $114.25. The impact to a portfolio due to this purchase was 0.42%. The holding were 233,559 shares as of .

Added: Kala Pharmaceuticals Inc (KALA)

Sofinnova Ventures Inc added to a holding in Kala Pharmaceuticals Inc by 67.69%. The purchase prices were between $3.69 and $8.79, with an estimated average price of $6.36. The stock is now traded at around $11.95. The impact to a portfolio due to this purchase was 0.39%. The holding were 1,114,520 shares as of .

Added: Homology Medicines Inc (FIXX)

Sofinnova Ventures Inc added to a holding in Homology Medicines Inc by 258.19%. The purchase prices were between $12.5 and $22.04, with an estimated average price of $17.1. The stock is now traded at around $13.66. The impact to a portfolio due to this purchase was 0.26%. The holding were 230,663 shares as of .

Sold Out: Regeneron Pharmaceuticals Inc (REGN)

Sofinnova Ventures Inc sold out a holding in Regeneron Pharmaceuticals Inc. The sale prices were between $336.18 and $494.43, with an estimated average price of $411.31.

Sold Out: Mirati Therapeutics Inc (MRTX)

Sofinnova Ventures Inc sold out a holding in Mirati Therapeutics Inc. The sale prices were between $69.78 and $128.86, with an estimated average price of $90.44.

Sold Out: Macrogenics Inc (MGNX)

Sofinnova Ventures Inc sold out a holding in Macrogenics Inc. The sale prices were between $4.28 and $12.11, with an estimated average price of $9.16.

Sold Out: Dermira Inc (DERM)

Sofinnova Ventures Inc sold out a holding in Dermira Inc. The sale prices were between $14.65 and $19.19, with an estimated average price of $18.32.

Sold Out: Arqule Inc (ARQL)

Sofinnova Ventures Inc sold out a holding in Arqule Inc. The sale prices were between $19.96 and $20.04, with an estimated average price of $20.

Sold Out: Seattle Genetics Inc (SGEN)

Sofinnova Ventures Inc sold out a holding in Seattle Genetics Inc. The sale prices were between $95.75 and $119.97, with an estimated average price of $110.87.



Here is the complete portfolio of Sofinnova Ventures Inc. Also check out:

1. Sofinnova Ventures Inc's Undervalued Stocks
2. Sofinnova Ventures Inc's Top Growth Companies, and
3. Sofinnova Ventures Inc's High Yield stocks
4. Stocks that Sofinnova Ventures Inc keeps buying

Rating: 0.0/5 (0 votes)

Comments

Please leave your comment:



Performances of the stocks mentioned by insider


User Generated Screeners


pjmason14Momentum
pascal.van.garsseHigh FCF-M2
kosalmmuse6
kosalmmuseBest one1
DBrizanall 2019Feb26
kosalmmuseBest one
DBrizanall 2019Feb25
kosalmmuseNice
kosalmmusehan
MsDale*52-Week Low
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)